Document Detail


Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells.
MedLine Citation:
PMID:  20483646     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cancer cells are characterized by increased aerobic glycolysis, which correlates with a negative prognosis. Although this correlation is well known, the mechanism of the elevated rate of glycolysis in cancer and the role of glycolytic enzymes have yet to be determined. The present work aims to evaluate the activity of the major enzymes that regulate glycolysis in breast cancer cell lines of varying aggressiveness. MCF10A, MCF-7 and MDA-mb-231 are human breast-derived cell lines with non-tumorigenic, tumorigenic and metastatic profiles, respectively. These cell lines have increasing degrees of glycolytic efficiency, i.e., lactate produced per glucose consumed, corresponding to their metastatic potential. Although, there are no differences in phosphofructokinase (PFK) or pyruvate kinase (PK) activities, the activity of hexokinase (HK) activity is higher in both tumorigenic cell lines compared to MCF10A cells. No difference in HK activity is observed between MCF-7 and MDA-mb-231 cells, suggesting that the difference in their glycolytic efficiency could not be attributed to this enzyme. However, we find that expression of the PFK-L isoform directly and strongly correlates with aggressiveness and glycolytic efficiency in these cell lines. Thus, we conclude that glycolytic efficiency, which is important for the survival of cancer cells, depends primarily on the preferential expression of PFK-L over the M and P isoforms.
Authors:
Patricia Zancan; Mauro Sola-Penna; Cristiane Marques Furtado; Daniel Da Silva
Related Documents :
8154316 - Interaction between human medulloblastomas and foetal rat brain aggregates in vitro.
19009596 - Ultrastructural characterization of the new ng97ht human-derived glioma cell line using...
7499346 - Human cathepsin g lacking functional glycosylation site is proteolytically processed an...
9286736 - Human endometriosis-derived permanent cell line (fbem-1): establishment and characteriz...
19911386 - Effects of sodium butyrate on the differentiation of pancreatic and hepatic progenitor ...
25170906 - Persistent effectivity of gas plasma-treated, long time-stored liquid on epithelial cel...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-04-18
Journal Detail:
Title:  Molecular genetics and metabolism     Volume:  100     ISSN:  1096-7206     ISO Abbreviation:  Mol. Genet. Metab.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-19     Completed Date:  2010-10-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9805456     Medline TA:  Mol Genet Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  372-8     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Affiliation:
Laboratório de Oncobiologia Molecular - LabOMol, Faculdade de Farmácia, UFRJ, Brazil. pzancan@ufrj.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Breast Neoplasms / enzymology*,  genetics*
Cell Line, Tumor
Female
Gene Expression Profiling*
Gene Expression Regulation, Enzymologic*
Gene Expression Regulation, Neoplastic*
Glycolysis / genetics*
Humans
Isoenzymes / genetics,  metabolism
Metabolome / genetics
Phosphofructokinase-1 / genetics*,  metabolism
RNA, Messenger / genetics,  metabolism
Chemical
Reg. No./Substance:
0/Isoenzymes; 0/RNA, Messenger; EC 2.7.1.11/Phosphofructokinase-1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Investigation of IGF2/ApaI and H19/RsaI polymorphisms in patients with cutaneous melanoma.
Next Document:  Self-perception of health status, mental health and quality of life among adults with diabetes resid...